Pharma Journalist -

Nexus Pharmaceuticals, Inc., a U.S.-based healthcare company and domestic pharmaceutical manufacturer, has received a patent covering applications of EMERPHED Ready-To-Use Ephedrine…
Read More...

Aurinia Pharmaceuticals Inc. announced the addition of two novel assets that will expand the Company’s rare autoimmune and kidney-related disease pipeline. “Over the past year, in…
Read More...

Virpax Pharmaceuticals, Inc. a company specializing in developing product candidates for pain management, CNS and anti-viral indications, today announced that it has received a written…
Read More...

Marrone Bio Innovations, Inc. an international leader in sustainable bioprotection and plant health solutions to support global agricultural needs, and Terramera, a global agtech leader…
Read More...

Exelixis, Inc. and Invenra, Inc. announced that they have expanded their discovery and licensing collaboration to include an additional 20 oncology targets. The augmented partnership…
Read More...

InnoCare, a leading biopharmaceutical company focusing on drug innovation for cancer and autoimmune diseases, announced the first subject dosed in clinical trial of novel TYK2 (Tyrosine…
Read More...

Over the last 2 decades, scientists and drug developers have been puzzled yet fascinated by Wnt/β-Catenin – its role in maintaining cancer stem cells, regulating numerous gene…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced the publication of new data on the durability of the Moderna COVID-19 vaccine…
Read More...

Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, announced the extension of its collaboration with…
Read More...

Artiva Biotherapeutics, Inc. (“Artiva”), an oncology company focused on developing and commercializing primary allogeneic natural killer (NK) cell therapies to treat cancer, announced…
Read More...